RON COHEN Insider Trading $ACOR ACORDA THERAPEUTICS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RON COHEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RON COHEN. RON COHEN is President and CEO in ACORDA THERAPEUTICS INC ($ACOR).
RON COHEN in ACORDA THERAPEUTICS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RON COHEN: President and CEO
Holdings: 495,400 shares
Current Value: $10,502,480
Latest Transaction: Dec 03 2014
$ACOR Market Capitalization: $941.09M
$ACOR Previous Close: $21.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of RON COHEN in ACORDA THERAPEUTICS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 03 2014 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 8.14 | 51,265 | 417,297 | 0 | |
| Dec 03 2014 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 35.59 | 34,394 | 1,224,144 | 495,400 | 529.8 K to 495.4 K (-6.49 %) |
| Dec 03 2014 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 8.14 | 51,265 | 417,297 | 529,794 | 478.5 K to 529.8 K (+10.71 %) |
| Mar 07 2014 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | A | 39.38 | 100,789 | 3,969,071 | 100,789 | |
| Mar 07 2014 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 17,786 | 0 | 478,529 | 460.7 K to 478.5 K (+3.86 %) |
| Dec 04 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 33.52 | 18,125 | 607,468 | 460,743 | 478.9 K to 460.7 K (-3.78 %) |
| Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 8,176 | 21,258 | 0 | |
| Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 113,141 | 294,167 | 0 | |
| Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 19,461 | 50,599 | 0 | |
| Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 31,945 | 83,057 | 113,141 | |
| Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 55,993 | 145,582 | 145,086 | |
| Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 42,062 | 109,361 | 201,079 | |
| Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 19,000 | 49,400 | 19,461 | |
| Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 8,176 | 21,258 | 478,868 | 470.7 K to 478.9 K (+1.74 %) |
| Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 113,141 | 294,167 | 470,692 | 357.6 K to 470.7 K (+31.64 %) |
| Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 19,461 | 50,599 | 357,551 | 338.1 K to 357.6 K (+5.76 %) |
| Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 34.82 | 5,840 | 203,349 | 338,090 | 343.9 K to 338.1 K (-1.70 %) |
| Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 34.25 | 26,105 | 894,096 | 343,930 | 370 K to 343.9 K (-7.05 %) |
| Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 31,945 | 83,057 | 370,035 | 338.1 K to 370 K (+9.45 %) |
| Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 34.02 | 55,993 | 1,904,882 | 338,090 | 394.1 K to 338.1 K (-14.21 %) |
| Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 55,993 | 145,582 | 394,083 | 338.1 K to 394.1 K (+16.56 %) |
| Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 34.04 | 61,062 | 2,078,550 | 338,090 | 399.2 K to 338.1 K (-15.30 %) |
| Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 42,062 | 109,361 | 399,152 | 357.1 K to 399.2 K (+11.78 %) |
| Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 19,000 | 49,400 | 357,090 | 338.1 K to 357.1 K (+5.62 %) |
| Jun 12 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 34.15 | 11,000 | 375,650 | 338,090 | 349.1 K to 338.1 K (-3.15 %) |
| Mar 08 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | A | 30.46 | 127,500 | 3,883,650 | 127,500 | |
| Mar 08 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 22,500 | 0 | 349,090 | 326.6 K to 349.1 K (+6.89 %) |
| Dec 05 2012 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 24.22 | 16,407 | 397,415 | 326,590 | 343 K to 326.6 K (-4.78 %) |
Page: 1